China Pharma Holdings, Inc.
CPHI
$0.82
-$0.02-2.38%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.39% | 22.36% | 32.70% | 32.76% | 16.97% |
| Total Depreciation and Amortization | 64.63% | -1.85% | -41.01% | -47.20% | -34.99% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -3,012.87% | -2,538.57% | -2,959.42% | 11.47% | 10.28% |
| Change in Net Operating Assets | 725.63% | 697.64% | 1,142.02% | 107.62% | 22.80% |
| Cash from Operations | -138.26% | 27.13% | 128.47% | 136.08% | 38.31% |
| Capital Expenditure | 98.39% | 98.97% | -54.43% | -234.62% | -72.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 82.12% | 82.12% | 82.12% | -- | -- |
| Cash from Investing | 85.59% | 86.78% | 64.15% | -1,488.46% | -221.58% |
| Total Debt Issued | -87.00% | 84.79% | 84.79% | -83.50% | -35.04% |
| Total Debt Repaid | 75.32% | -99.40% | -126.59% | 64.89% | 41.80% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4.98% | -152.56% | -772.40% | -640.59% | 66.06% |
| Foreign Exchange rate Adjustments | 154.38% | 45.02% | 101.98% | -236.65% | -330.52% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -180.05% | 42.69% | 64.64% | 30.72% | 29.66% |